Jh. Day et al., RISK ASSESSMENT IN DETERMINING SYSTEMIC REACTIVITY TO HONEYBEE STINGSIN STING-THREATENED INDIVIDUALS, Journal of allergy and clinical immunology, 93(4), 1994, pp. 691-705
We evaluated the diagnostic parameters (sting rate, venom-specific RAS
T IgE, venom-specific RAST IgG, venom-specific IgG(4), venom-specific
skin test) of 224 individuals at risk of honeybee sting, assigned them
a level of risk on the basis of a hypothetical risk model, and then s
ting challenged each subject with a live honeybee. Of the 70 subjects
at the lowest risk level, only three (4.3%) experienced equivocal or m
ild systemic reactions, whereas eight (72.7%) of the 11 at the highest
risk level experienced systemic reactions, of which five (45.5% were
severe. Increase in risk level was associated with an ina eased propor
tion of systemic reactions (p < 0.001). Of the individual diagnostic p
arameters s, venom-specific RAST IgE was the best single predictor of
reactivity (likelihood ratio = 0.759, p < 0.01). Venom-specific skin t
esting at a concentration of 0.1 mu g/ml was a better discriminator th
an a concentration of 1.0 mu g/ml but did not predict one severe syste
mic reaction. Three methods of prediction of risk and severity of reac
tion were examined; the one that assessed risk in the most clinically,
useful manner was similar to the hypothetical risk model. This model
compared well with classical methods of risk assessment and may be use
d to assess high-risk individuals exposed to honeybees when management
could include prophylactic immunotherapy.